<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="55194">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01732432</url>
  </required_header>
  <id_info>
    <org_study_id>210/12</org_study_id>
    <nct_id>NCT01732432</nct_id>
  </id_info>
  <brief_title>Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)</brief_title>
  <acronym>EAOC</acronym>
  <official_title>Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC) - Epidemiological and Molecular Pathological Aspects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <authority>Switzerland: Federal Office of Public Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a relationship exists between a previously
      established diagnosis of endometriosis and the consecutive risk of developing a clear cell
      or endometrioid ovarian carcinoma. All histopathological records since 1980 with these
      diagnoses (endometriosis, clear cell and endometrioid ovarian carcinoma) will be reviewed.
      Cancer registry data will be assessed to investigate differences in survival of women with
      endometriosis-associated ovarian carcinomas and those ovarian carcinoma patients without
      previous diagnosis of endometriosis.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>incidence and clinical outcome of endometriosis-associated ovarian carcinomas</measure>
    <time_frame>30 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Endometrioid Carcinoma</condition>
  <condition>Clear Cell Carcinoma</condition>
  <condition>Endometriosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        primary care hospital, university hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  endometrioid ovarian carcinoma

          -  clear cell ovarian carcinoma

          -  endometriosis, atypical endometriosis

          -  borderline tumors with endometriosis

        Exclusion Criteria:

          -  undifferentiated carcinomas

          -  germ cell tumors

          -  sex cord-stromal tumors
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Athanassios Dellas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Basel, University of Basel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ellen C Obermann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Pathology, University Hospital Basel, University of Basel</affiliation>
  </overall_official>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>November 18, 2012</lastchanged_date>
  <firstreceived_date>November 18, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Basel, Switzerland</investigator_affiliation>
    <investigator_full_name>Athanassios Dellas, MD</investigator_full_name>
    <investigator_title>Associate-Professor of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Endometriosis</mesh_term>
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Adenocarcinoma, Clear Cell</mesh_term>
    <mesh_term>Adenomyoepithelioma</mesh_term>
    <mesh_term>Carcinoma, Endometrioid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
